Tenofovir vs. Entecavir after treatment for HBV-associated HCC

Published Date: 08 Mar 2023

This review compared the effectiveness of entecavir and tenofovir in reducing relapses and mortality after treatment for HBV-related hepatocellular carcinoma.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Novel probes to label macrophages associated with cancer progression using a selective dye

2.

Chronic stress and obesity work together to accelerate pancreatic cancer development and growth, study finds

3.

Most women with early-stage breast cancer can anticipate living long lives, according to experts.

4.

Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.

5.

Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot